CXCR3 blockade combined with cyclosporine A alleviates acute graft-versus-host disease by inhibiting alloreactive donor T cell responses in a murine model-Reference-Cited by-同舟云学术

CXCR3 blockade combined with cyclosporine A alleviates acute graft-versus-host disease by inhibiting alloreactive donor T cell responses in a murine model

Published:2018-02 Issue: Volume:94 Page:82-90
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Miao Shengchao,Tang Bo,Liu Huihui,Wang Zhenhua,Shi Yongjin,Dong Yujun,Liu Wei,Qin Chenchen,Ren Hanyun

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference40 articles.

1. Identification and validation of biomarkers associated with acute and chronic graft versus host disease;Ahmed;Bone Marrow Transpl.,2015

2. Small molecule CXCR3 antagonists;Andrews;J. Med. Chem.,2016

3. Prevention of acute graft-versus-host disease by magnetic nanoparticles of Fe(3)O(4) combined with cyclosporin A in murine models;Cheng;Int. J. Nanomed.,2011

4. Current and emerging strategies for the prevention of graft-versus-host disease;Choi;Nat. Rev. Clin. Oncol.,2014

5. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin;Cooke;Blood,1996

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term CXCR3 antagonist AMG487 mitigated acute graft-versus-host disease by inhibiting T cell activation in a murine model;Transplant Immunology;2024-12

2. Blockade of CCR5 and CXCR3 attenuates murine acute graft-versus-host disease through modulating donor-derived T-cell distribution and function;International Immunology;2024-05-23

3. AMG487 alleviates influenza A (H1N1) virus‐induced pulmonary inflammation through decreasing IFN‐γ‐producing lymphocytes and IFN‐γ concentrations;British Journal of Pharmacology;2024-03-18

4. Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 study;Allergy;2023-11-20

5. CXCL9 inhibition does not ameliorate disease in murine models of both primary and secondary hemophagocytic lymphohistiocytosis;Scientific Reports;2023-07-29